{
  "disease_name": "Familial steroid-resistant nephrotic syndrome with adrenal insufficiency",
  "orpha_code": "506334",
  "drugs": [
    {
      "name": "ALKINDI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/505896?name=506334&mode=orpha&region=",
      "regulatory_id": "505896",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "ALKINDI(Tradename                        - 09/02/2018)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "ALKINDI(Tradename                        - 09/02/2018)",
        "(Tradename                        - 09/02/2018)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/505888?name=506334&mode=orpha&region=&status=all",
          "text": "ALKINDI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/505896?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PLENADREN",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/352529?name=506334&mode=orpha&region=",
      "regulatory_id": "352529",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "PLENADREN(Tradename                        - 03/11/2011)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "PLENADREN(Tradename                        - 03/11/2011)",
        "(Tradename                        - 03/11/2011)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/352513?name=506334&mode=orpha&region=&status=all",
          "text": "PLENADREN",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/352529?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid",
      "substance_url": "/en/drug/substance/444708?name=506334&mode=orpha&region=&status=all",
      "substance_id": "444708",
      "regulatory_url": "/en/drug/regulatory/444712?name=506334&mode=orpha&region=",
      "regulatory_id": "444712",
      "orpha_substance_code": "ORPHA:306648",
      "details": [
        "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid(Medicinal product                        - 19/06/2015)Disease(s) concernedORPHA:892 Von Hippel-Lindau diseaseORPHA:730 Autosomal dominant polycystic kidney diseaseORPHA:34149 Autosomal dominant tubulointerstitial kidney diseaseORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosisORPHA:90061 Non-infectious posterior uveitisORPHA:93545 Renal or urinary tract malformationORPHA:93548 Glomerular diseaseORPHA:93587 Genetic cystic renal diseaseORPHA:93603 Rare renal tubular diseaseORPHA:306648 Non-infectious anterior uveitis",
        "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid(Medicinal product                        - 19/06/2015)",
        "(Medicinal product                        - 19/06/2015)",
        "Disease(s) concernedORPHA:892 Von Hippel-Lindau diseaseORPHA:730 Autosomal dominant polycystic kidney diseaseORPHA:34149 Autosomal dominant tubulointerstitial kidney diseaseORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosisORPHA:90061 Non-infectious posterior uveitisORPHA:93545 Renal or urinary tract malformationORPHA:93548 Glomerular diseaseORPHA:93587 Genetic cystic renal diseaseORPHA:93603 Rare renal tubular diseaseORPHA:306648 Non-infectious anterior uveitis",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/444708?name=506334&mode=orpha&region=&status=all",
          "text": "3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/892",
          "text": "ORPHA:892 Von Hippel-Lindau disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/730",
          "text": "ORPHA:730 Autosomal dominant polycystic kidney disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/34149",
          "text": "ORPHA:34149 Autosomal dominant tubulointerstitial kidney disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/88924",
          "text": "ORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/90061",
          "text": "ORPHA:90061 Non-infectious posterior uveitis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93545",
          "text": "ORPHA:93545 Renal or urinary tract malformation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93548",
          "text": "ORPHA:93548 Glomerular disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93587",
          "text": "ORPHA:93587 Genetic cystic renal disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/93603",
          "text": "ORPHA:93603 Rare renal tubular disease",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/306648",
          "text": "ORPHA:306648 Non-infectious anterior uveitis",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/444712?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "ORPHA:730 Autosomal dominant polycystic kidney disease\n                                \n\n\n\n\n                                    ORPHA:34149 Autosomal dominant tubulointerstitial kidney disease\n                                \n\n\n\n\n                                    ORPHA:88924 Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis\n                                \n\n\n\n\n                                    ORPHA:90061 Non-infectious posterior uveitis\n                                \n\n\n\n\n                                    ORPHA:93545 Renal or urinary tract malformation\n                                \n\n\n\n\n                                    ORPHA:93548 Glomerular disease\n                                \n\n\n\n\n                                    ORPHA:93587 Genetic cystic renal disease\n                                \n\n\n\n\n                                    ORPHA:93603 Rare renal tubular disease\n                                \n\n\n\n\n                                    ORPHA:306648 Non-infectious anterior uveitis\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hydrocortisone",
      "substance_url": "/en/drug/substance/505909?name=506334&mode=orpha&region=&status=all",
      "substance_id": "505909",
      "regulatory_url": "/en/drug/regulatory/134118?name=506334&mode=orpha&region=",
      "regulatory_id": "134118",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "Hydrocortisone(Medicinal product                        - 20/03/2007)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "Hydrocortisone(Medicinal product                        - 20/03/2007)",
        "(Medicinal product                        - 20/03/2007)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/505909?name=506334&mode=orpha&region=&status=all",
          "text": "Hydrocortisone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/134118?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Prasterone",
      "substance_url": "/en/drug/substance/97925?name=506334&mode=orpha&region=&status=all",
      "substance_id": "97925",
      "regulatory_url": "/en/drug/regulatory/133836?name=506334&mode=orpha&region=",
      "regulatory_id": "133836",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "Prasterone(Medicinal product                        - 28/07/2003)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "Prasterone(Medicinal product                        - 28/07/2003)",
        "(Medicinal product                        - 28/07/2003)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/97925?name=506334&mode=orpha&region=&status=all",
          "text": "Prasterone",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133836?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hydrocortisone (modified release tablet)",
      "substance_url": "/en/drug/substance/65883?name=506334&mode=orpha&region=&status=all",
      "substance_id": "65883",
      "regulatory_url": "/en/drug/regulatory/134049?name=506334&mode=orpha&region=",
      "regulatory_id": "134049",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "Hydrocortisone (modified release tablet)(Medicinal product                        - 22/05/2006)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "Hydrocortisone (modified release tablet)(Medicinal product                        - 22/05/2006)",
        "(Medicinal product                        - 22/05/2006)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/65883?name=506334&mode=orpha&region=&status=all",
          "text": "Hydrocortisone (modified release tablet)",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/134049?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "KHINDIVI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/704611?name=506334&mode=orpha&region=",
      "regulatory_id": "704611",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "KHINDIVI(Tradename                        - 28/05/2025)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "KHINDIVI(Tradename                        - 28/05/2025)",
        "(Tradename                        - 28/05/2025)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/704608?name=506334&mode=orpha&region=&status=all",
          "text": "KHINDIVI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/704611?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Alkindi Sprinkle",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/623088?name=506334&mode=orpha&region=",
      "regulatory_id": "623088",
      "orpha_substance_code": "ORPHA:101958",
      "details": [
        "Alkindi Sprinkle(Tradename                        - 29/09/2020)Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "Alkindi Sprinkle(Tradename                        - 29/09/2020)",
        "(Tradename                        - 29/09/2020)",
        "Disease(s) concernedORPHA:101958 Primary adrenal insufficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/623087?name=506334&mode=orpha&region=&status=all",
          "text": "Alkindi Sprinkle",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/101958",
          "text": "ORPHA:101958 Primary adrenal insufficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/623088?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=506334&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=506334&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=506334&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=506334&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=506334&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=506334&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=506334&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=506334&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=506334&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=506334&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:04:30.274770",
  "run_number": 1,
  "total_drugs_found": 11,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Familial+steroid-resistant+nephrotic+syndrome+with+adrenal+insufficiency&orphaCode=506334&name=506334&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Familial steroid-resistant nephrotic syndrome with adrenal insufficiency",
    "orphaCode": "506334",
    "name": "506334",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}